Novavax (NVAX) Stock Up 8% as FDA Approves Updated Covid Vaccine
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential ...
Read moreCovid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out. Makers ...
Read moreWith the second phase concluded, the Phase 3 melanoma trial will begin soon. Biotechnology company Moderna Inc (NASDAQ: MRNA) experienced ...
Read moreBoth COVID-19 sales and Paxlovid contributed immensely to the impressive financial report Pfizer announced for Q2 2022.Pharmaceutical and biotechnological corporation ...
Read moreExcept for its recent jump, Moderna stock has been at the lows. The remarkable Q1 2022 performance may give Moderna ...
Read moreAccording to the eZTracker website, the customer only needs to scan the QR code on the packaging to spontaneously confirm ...
Read morePfizer CEO said that it is not clear if a fourth dose is required. He explained that Pfizer would conduct ...
Read moreModerna has come under fire in recent times as many countries in Europe are boycotting its vaccine for that of ...
Read moreThe boost from the COVID vaccine sales, among other factors, has pushed Johnson & Johnson to increase its full-year earnings ...
Read moreSeveral crypto projects, including Icon (ICX) and VeChain (VET), are rolling out features to accommodate vaccine passports. But Cardano will ...
Read moreThe updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential...
Covid vaccine stocks, including Moderna, BioNTech, and Novavax have all closed higher as new vaccinations and treatments roll out. Makers...
With the second phase concluded, the Phase 3 melanoma trial will begin soon. Biotechnology company Moderna Inc (NASDAQ: MRNA) experienced...
Both COVID-19 sales and Paxlovid contributed immensely to the impressive financial report Pfizer announced for Q2 2022.Pharmaceutical and biotechnological corporation...
Except for its recent jump, Moderna stock has been at the lows. The remarkable Q1 2022 performance may give Moderna...
© 2018 JNews by Jegtheme.